Kevin Benson highlighted that the TITAN 2 study demonstrates the Altaviva ITNM system as a safe, minimally invasive, and durable solution for real-world patients who have failed prior overactive bladder treatments.
Kevin Benson, MD
Advertisement
Kevin Benson, MD, Urogynecologist, Sanford Health; Investigator, TITAN 2 pivotal study.
Articles by Kevin Benson, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
2
FDA grants 510(k) clearance to Roche's cobas BV/CV assay
3
Natural Cycles receives FDA clearance for AI-powered fertility algorithm
4
Late preterm hypoglycemia not tied to neurodevelopment at age 6
5